AKIRIN2

akirin 2

Basic information

Region (hg38): 6:87674860-87702233

Previous symbols: [ "C6orf166" ]

Links

ENSG00000135334NCBI:55122OMIM:615165HGNC:21407Uniprot:Q53H80AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the AKIRIN2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the AKIRIN2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
5
clinvar
5
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
2
2
non coding
0
Total 0 0 5 0 0

Variants in AKIRIN2

This is a list of pathogenic ClinVar variants found in the AKIRIN2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-87675861-G-A Benign (Feb 25, 2018)785176
6-87677829-G-A not specified Uncertain significance (Sep 22, 2023)3107064
6-87681616-T-C Benign (Nov 19, 2018)773881
6-87681649-G-A not specified Uncertain significance (Mar 08, 2024)3107059
6-87681697-C-T not specified Uncertain significance (Sep 29, 2023)3107054
6-87701602-G-C not specified Uncertain significance (Mar 24, 2023)2561866
6-87701623-G-A not specified Uncertain significance (Dec 06, 2021)2208760

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
AKIRIN2protein_codingprotein_codingENST00000257787 527138
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9240.0764125722041257260.0000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.306197.20.6280.000005431267
Missense in Polyphen1638.0870.42009486
Synonymous-1.124637.31.230.00000208403
Loss of Function3.03112.60.07928.76e-7132

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00002660.0000264
Middle Eastern0.000.00
South Asian0.00003470.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Required for the innate immune response. Downstream effector of the Toll-like receptor (TLR), TNF and IL-1 beta signaling pathways leading to the production of IL-6. Forms a complex with YWHAB that acts to repress transcription of DUSP1 (By similarity). {ECO:0000250}.;

Recessive Scores

pRec
0.118

Haploinsufficiency Scores

pHI
0.881
hipred
Y
hipred_score
0.664
ghis
0.640

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.967

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Akirin2
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;positive regulation of cell population proliferation;embryo development ending in birth or egg hatching;positive regulation of endopeptidase activity;response to lipopolysaccharide;positive regulation of interleukin-6 production;innate immune response;positive regulation of transcription by RNA polymerase II
Cellular component
nucleus;nucleoplasm;transcriptional repressor complex
Molecular function
protein binding;enzyme binding